LIGAND PHARMACEUTICALS INC
LGND·53220K504·US·Common Stock·Healthcare - Biotechnology-13D/G
LGND (LIGAND PHARMACEUTICALS INC) is held by 174 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($980.2M), Invesco Ltd. ($379.8M), VANGUARD PORTFOLIO MANAGEMENT LLC ($359.8M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 108 funds bought LGND.
Who's Trading
Source dates: Price Aug 31, 2026 · Insiders Aug 14, 2026 · Activists Aug 13, 2026 · Congress Jun 8, 2026
Top Holders
Showing 1-20 of 194
Continue exploring
Other Healthcare stocks held by institutions
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer